Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Fasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma (blood eosinophilic count ≥300 cells/μL or ≥150 cells/μL if on oral corticosteroid treatment) inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.

Fasenra Indications/Uses

Manufacturer:

AstraZeneca

Marketer:

AstraZeneca